Counterpoint Quantitative Equity ETF $CPAI Stock Holdings Boosted by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC boosted its position in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) by 5.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,300,416 shares of the company’s stock after buying an additional 61,500 shares during the quarter. Counterpoint Quantitative Equity ETF makes up about 4.1% of Counterpoint Mutual Funds LLC’s holdings, making the stock its 5th largest position. Counterpoint Mutual Funds LLC owned about 40.64% of Counterpoint Quantitative Equity ETF worth $51,357,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in Counterpoint Quantitative Equity ETF by 5.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,461 shares of the company’s stock worth $255,000 after acquiring an additional 331 shares during the last quarter. Global Assets Advisory LLC purchased a new position in shares of Counterpoint Quantitative Equity ETF in the third quarter valued at $1,109,000. Inscription Capital LLC grew its position in shares of Counterpoint Quantitative Equity ETF by 5.1% in the third quarter. Inscription Capital LLC now owns 31,650 shares of the company’s stock valued at $1,250,000 after purchasing an additional 1,550 shares in the last quarter. Concurrent Investment Advisors LLC raised its stake in shares of Counterpoint Quantitative Equity ETF by 59.4% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 72,844 shares of the company’s stock valued at $2,877,000 after purchasing an additional 27,135 shares during the period. Finally, U.S. Capital Wealth Advisors LLC lifted its holdings in Counterpoint Quantitative Equity ETF by 49.3% during the 3rd quarter. U.S. Capital Wealth Advisors LLC now owns 93,556 shares of the company’s stock worth $3,695,000 after purchasing an additional 30,896 shares in the last quarter.

Counterpoint Quantitative Equity ETF Stock Down 0.5%

Shares of NYSEARCA CPAI opened at $43.37 on Tuesday. The company has a market cap of $175.21 million, a P/E ratio of -52,002.40 and a beta of 1.25. Counterpoint Quantitative Equity ETF has a 52 week low of $28.48 and a 52 week high of $45.09. The business has a 50-day simple moving average of $42.56 and a two-hundred day simple moving average of $40.06.

Counterpoint Quantitative Equity ETF Announces Dividend

The company also recently disclosed an annual dividend, which was paid on Wednesday, December 17th. Stockholders of record on Friday, December 12th were given a $0.3577 dividend. This represents a dividend yield of 89.0%. The ex-dividend date was Friday, December 12th. Counterpoint Quantitative Equity ETF’s dividend payout ratio (DPR) is -16,786.57%.

Counterpoint Quantitative Equity ETF Company Profile

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.